BRAFTOVI caps 75 mg 168 pce

7680667950042 CH-66795 L01EC03 07.16.1.

Active substances:

BRAFTOVI caps 75 mg 168 pce
BRAFTOVI caps 75 mg 168 pce
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6679502
CPT
-
Packaging group
168
Unit
Kapsel(n)
Composition
encorafenibum 75 mg, copovidonum K 28, poloxamerum 188, cellulosum microcristallinum, acidum succinicum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), Drucktinte: lacca, E 172 (nigrum), pro capsula.

Articles (1)

Braftovi 75 mg, Hartkapseln
Kapseln
168
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
02/09/2026
Professional SmPC
Français
02/09/2026
Professional SmPC
Italien
02/09/2026
Patient information leaflet
Allemand
20/08/2026
Patient information leaflet
Français
20/08/2026
Patient information leaflet
Italien
20/08/2026

Detailed composition

Substance Quantity Type Category
encorafenibum
75.0 MG Substance Wirkstoff (Principe actif)
copovidonum K 28
- Substance HNIDK
poloxamerum 188
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
acidum succinicum
- Substance HNIDK
crospovidonum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 172 (nigrum)
- Substance FTODK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK

Reimbursement information

Public price
CHF 5464.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2019

Authorization holder

Pierre Fabre Pharma SA

4052 Basel

Authorization information

Swissmedic authorization number
66795
Drug name
Braftovi, Hartkapseln
Galenic form
KAHA
ATC Code
L01EC03
Authorization status
Z
Dispensation category
A
First authorization
01/11/2019
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Melanom mit BRAF-V600-Mutation in Kombination mit Binimetinib, metastasiertes Kolorektalkarzinom (CRC) mit einer BRAF-V600E-Mutation in Kombination mit Cetuximab NSCLC mit BRAF-V600E-Mutation in Kombination mit Binimetinib

Packaging details

Description (FR)
BRAFTOVI caps 75 mg 168 pce
Description (DE)
BRAFTOVI Kaps 75 mg 168 Stk
Market launch
01/11/2019
Narcotic (BTM)
No

Other packaging sizes

BRAFTOVI caps 50 mg 28 pce
28 KAP
View
BRAFTOVI caps 75 mg 42 pce
42 KAP
View
Buy us a coffee Explore the data